Consensus document for lipid profile testing and reporting in Spanish clinical laboratories.

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.

Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.

Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile? / Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿Qué parámetros debe incluir un perfil lipídico básico?

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.

Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles ¿Qué parámetros debe incluir un perfil lípido básico? / Consensus document to determine and report the lipid profile in spanish clinical laboratories. Which parameters should a basic lipid profile include?

Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro país. El control adecuado de las alteraciones del metabolismo lipídico es un reto clave en prevención cardiovascular que está lejos de alcanzarse en la práctica clínica real. Existe una gran heterogeneidad en los informes del metabolismo lipídico de los laboratorios clínicos españoles, lo que puede contribuir al mal control del mismo. Por ello, un grupo de trabajo de las principales sociedades científicas implicadas en la atención de los pacientes de riesgo vascular, hemos elaborado este documento con una propuesta básica de consenso sobre la determinación del perfil lipídico básico en prevención cardiovascular, recomendaciones para su realización y unificación de criterios para incorporar los objetivos de control lipídico adecuados al riesgo vascular de los pacientes en los informes de laboratorio.(AU)

Cardiovascular diseases (CVD) continue to be the main cause of death in Spain. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from achieved in real clinical practice. There is a major heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor monitoring. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has drawn up this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its implementation and combining the criteria to incorporate the lipid monitoring goals suitable for the vascular risk of the patients in the laboratory reports.(AU)

Utilidad de la ecografía clínica en la valoración de la patología ocular urgente no traumática / Usefulness of point-of-care ultrasound for the evaluation of non-traumatic eye emergencies

El papel de la ecografía clínica o Point-of-Care Ultrasound (POCUS) en los pacientes con patología urgente se ha expandido exponencialmente en los últimos años. Con la ecografía clínica los médicos pueden realizar una evaluación rápida y decidir cómo actuar en situaciones en las que el tiempo es vital.La ecografía ocular es una de las aplicaciones desarrolladas más recientemente. En los pacientes con patología ocular grave no traumática tiene numerosos usos clínicamente relevantes: desprendimiento de retina, oclusión de la arteria central de la retina o patologías del nervio óptico, entre otras.La técnica está ampliamente disponible, es de fácil realización y puede proporcionar información incluso cuando la fundoscopia es imposible.En esta revisión describimos las bases de la ecografía clínica ocular centrándonos en el manejo de las principales patologías oftalmológicas urgentes no traumáticas a las que se puede enfrentar el médico en su práctica clínica. (AU)

The role of clinical ultrasound or Point-of-Care Ultrasound (POCUS) in patients with urgent pathology has expanded exponentially in recent years. With clinical ultrasound, physicians can make a quick assessment and decide how to act in time critical situations.Ocular ultrasound is one of the most recently developed applications. In patients with severe non-traumatic ocular pathology it has numerous clinically relevant uses: retinal detachment, occlusion of the central retinal artery or optic nerve pathologies, among others.The technique is widely available, easy to perform, and can provide information even when fundoscopy is impossible.In this review, we describe the bases of clinical ocular ultrasound, focusing on the management of the main non-traumatic urgent ophthalmological pathologies that the physician may face in their clinical practice. (AU)

Usefulness of point-of-care ultrasound for the evaluation of non-traumatic eye emergencies. / Utilidad de la ecografía clínica en la valoración de la patología ocular urgente no traumática.

The role of clinical ultrasound or Point-of-Care Ultrasound (POCUS) in patients with urgent pathology has expanded exponentially in recent years. With clinical ultrasound, physicians can make a quick assessment and decide how to act in time critical situations. Ocular ultrasound is one of the most recently developed applications. In patients with severe non-traumatic ocular pathology it has numerous clinically relevant uses: retinal detachment, occlusion of the central retinal artery or optic nerve pathologies, among others. The technique is widely available, easy to perform, and can provide information even when fundoscopy is impossible. In this review, we describe the bases of clinical ocular ultrasound, focusing on the management of the main non-traumatic urgent ophthalmological pathologies that the physician may face in their clinical practice.

¿Ha cambiado el paradigma de la prevención del ictus en los pacientes con diabetes? / Has the paradigm of stroke prevention changed in patients with diabetes?

No disponible

Yodo tópico y glándula tiroidea. ¿Se debe tomar alguna precaución? / Topical iodine and thyroid gland. Do we have to take some caution?

No disponible

Isquemia arterial crítica de miembros inferiores en los pacientes muy ancianos: un problema creciente / Critical limb ischemia in the very elderly patients: A growing problem

No disponible

Utilidad de los modelos predictivos de embolia pulmonar / Usefulness of predictive models of pulmonary embolism

ANTECEDENTES: Ante la sospecha de embolia pulmonar (EP), las guías recomiendan el empleo de escalas de probabilidad clínica, medición del dímero D y, en determinados casos, confirmar mediante angiografía pulmonar mediante tomografía computarizada (APTC) o gammagrafía. Recientemente se ha planteado ajustar el dímero D según edad o usar escalas más sencillas (algoritmo YEARS) para una mejor selección de los pacientes. OBJETIVO: Definir el grado de aplicación de las guías en nuestra población y comparar sensibilidad, especificidad y valores predictivos positivo y negativo de los diferentes modelos diagnósticos: modelo estándar (Wells 2 categorías+dímero D), modelo ajustado por edad (Wells 2 categorías+dímero D ajustado por edad), algoritmo YEARS. MATERIAL Y MÉTODOS: Estudio retrospectivo de todos los pacientes que se sometieron en nuestro centro a APTC para diagnóstico de EP durante un año. RESULTADOS: De 618 casos (el 85,4% de las APTC) iniciales se incluyeron 544 pacientes. Se diagnosticaron 113 EP (20,8%). El grado de aplicación del modelo estándar fue muy alto (90,1%) y demostró presentar la mejor relación sensibilidad y valor predictivo negativo (sensibilidad=1, valor predictivo negativo=1). Los nuevos modelos podrían reducir el número de exploraciones (17; 3,2% modelo ajustado por edad y 48; 8,8% modelo YEARS) con riesgo de falsos negativos (2 EP [1,8%] no diagnosticadas respectivamente). CONCLUSIONES: Los modelos diagnósticos actuales para EP llevan a la realización de un gran número de exploraciones innecesarias. Los nuevos modelos podrían reducir el número de APTC aunque con un mínimo riesgo de falsos negativos

BACKGROUND: Faced with the suspicion of pulmonary embolism (PE), the guidelines recommend the use of clinical probability scales, measurement of D-dimer and, in certain cases, confirmation by pulmonary angiography by computed tomography (CTPA) or scintigraphy. Recently, it has been proposed to adjust the D-dimer according to age or use simpler scales (YEARS algorithm) for a better selection of patients. OBJECTIVE: To define the degree of application of the guidelines in our population and compare sensitivity, specificity and positive and negative predictive values of the different diagnostic models: Standard model (Wells 2 categories+D-dimer), Model adjusted for age (Wells 2 categories+D-dimer adjusted for age), YEARS algorithm. MATERIAL AND METHODS: A retrospective study of all patients who underwent APTC at our centre for the diagnosis of PE over one year. RESULTS: Of 618 cases (85.4% of initial APTC), 544 patients were included. A total of 113 EPs were diagnosed (20.8%). The degree of application of the standard model was very high (90.1%) and proved to have the best sensitivity and negative predictive value ratio (sensitivity=1.0, negative predictive value=1.0). The new models could reduce the number of scans (17, 3.2% model adjusted for age and 48, 8.8% model YEARS) with a risk of false negatives (2 PE [1.8%] undiagnosed respectively). CONCLUSIONS: The current diagnostic models for PE lead to a large number of unnecessary explorations. The new models could reduce the number of APTC although with a minimum risk of false negatives

Pharmacological management of post-stroke depression.

Introduction: Post-stroke depression (PSD) is a common clinical problem affecting approximately one-third of stroke survivors. PSD is associated with poor functional outcome and higher morbidity and mortality rates. Currently, uncertainty remains regarding optimal pharmacological strategies for its prevention and treatment.Areas covered: This article reviews the state of the current literature on pharmacologic intervention strategies for PSD, providing a summary of the most recent evidence to support pharmacological treatment in PSD.Expert opinion: Experimental and clinical research have increased our knowledge on PSD, although unanswered questions still remain regarding the best time to begin treatment, the effect of the antidepressants in areas other than emotion, or their capability to reduce mortality in stroke patients, among others.Currently, though numerous trials and meta-analyses suggest that antidepressants are effective in treating PSD and guidelines recommend their use for PSD, in the daily clinical practice, only a minority of patients are properly assessed and treated. Therefore, though further evidence is needed to clarify the real role of antidepressants in patients with stroke, physicians and other healthcare professionals must be familiar with the pharmacological treatment of PSD, in order to improve the outcome and increase the quality of life of this vulnerable group of patients.